Volume 24, Number 2—February 2018
Research
Borrelia miyamotoi Infections in Humans and Ticks, Northeastern China
Table
Characteristic |
Patient no. | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
|
Epidemiologic features | ||||||||||||||
Sex | F | M | F | M | M | M | M | M | M | F | M | M | M | M |
Age, y | 46 | 30 | 31 | 47 | 41 | 43 | 49 | 52 | 10 | 65 | 36 | 48 | 52 | 43 |
History of tick bite | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
Place of exposure to ticks | Forest | Forest | Forest | Forest | Forest | Forest | Forest | Forest | Home | Forest | Forest | Forest | Forest | Forest |
Tick bite location | Arm | Trunk | Neck | Ear | Leg | Trunk | Trunk | Trunk | Scalp | Arm | Trunk | Trunk | Trunk | Trunk |
Days from tick
exposure to
illness onset |
18 |
28 |
16 |
5 |
3 |
7 |
7 |
25 |
4 |
10 |
26 |
6 |
4 |
40 |
Clinical manifestations | ||||||||||||||
Fever, °C | 38.4 | 39.7 | 39 | 39 | – | – | 39.6 | 38.5 | – | – | – | – | – | – |
Asthenia | + | + | + | + | – | – | – | – | + | – | – | – | – | – |
Headache | + | + | + | + | – | – | – | + | – | – | – | + | – | – |
Anorexia | + | – | + | + | – | – | – | + | – | – | – | + | – | – |
Myalgia | – | – | – | – | – | – | + | – | – | – | – | – | – | – |
Arthralgia | – | + | + | – | – | – | + | – | – | – | – | – | – | – |
Lymphadenopathy | – | – | – | – | – | – | – | – | + | – | – | – | – | – |
Rash | – | – | – | – | – | – | – | – | – | + | – | – | – | – |
Eschar |
– |
– |
– |
– |
– |
– |
– |
– |
+ |
– |
– |
– |
– |
– |
Laboratory findings† | ||||||||||||||
Leukocytes, 109/L | 7.9 | 9.6 | 8.9 | 11.7 | 5.1 | NA | 4.3 | NA | 9.9 | 7.6 | NA | 6.3 | 5.4 | 11.8 |
Lymphocytes, 109 cells/L | 0.9 | 0.6 | 0.9 | 1.8 | 1.7 | NA | 0.3 | NA | 3 | 2.2 | NA | 2 | 2.5 | 1.2 |
Neutrophils, 109 cells/L | 7.4 | 5.5 | 8.4 | 8.3 | 2.7 | NA | 3.9 | NA | 6 | 16.9 | NA | 4.2 | 2.7 | 9.7 |
Platelets, 109/L | 164 | 130 | 173 | 210 | 218 | NA | 79 | NA | 298 | 200 | NA | 172 | 137 | 269 |
AST, U/L | 94.4 | 30.5 | 13.9 | 31 | 16.7 | NA | 60 | NA | 11.4 | NA | NA | 22 | 10.7 | NA |
ALT, U/L | 124.6 | 17.8 | 12.1 | 26.1 | 24.3 | NA | 71.6 | NA | 8 | NA | NA | 39.5 | 16.2 | NA |
Hospital stay (d) | Yes (17) | Yes (3) | Yes (15) | Yes (20) | No | No | No | No | No | No | No | No | No | No |
Co-infection | No | No | No | CRT | CRT | AC | No | No | No | No | No | No | No | No |
*AC, Anaplasma capra; ALT, alanine aminotransferase; AST: aspartate aminotransferase; CRT, Candidatus Rickettsia tarasevichiae; NA, not applicable; +, positive; –, negative.
†Normal ranges: leukocyte count, 4–10 × 109 cells/L; lymphocyte count, 0.8–4 × 109 cells/L; neutrophil count, 2–7 × 109 cells/L; platelet count, 100–300 × 109/L; AST, 8–40 U/L; ALT, 5–40 U/L.
1These authors contributed equally to this article.
Page created: January 17, 2018
Page updated: January 17, 2018
Page reviewed: January 17, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.